Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other financing activities (2016 - 2025)

Altimmune (ALT) has disclosed Other financing activities for 7 consecutive years, with $350000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities changed N/A to $350000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $672000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $1.1 million for FY2025, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was $350000.0 at Altimmune, up from $322000.0 in the prior quarter.
  • The five-year high for Other financing activities was $350000.0 in Q4 2025, with the low at $322000.0 in Q3 2025.